NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP: FDA Alignment, 70,000-Patient Real-World Data, and a Debt-Free Balance Sheet Position NRXP for Transformational 2026 Catalysts
Neurologist Dr. Brendan Bauer and Nurse Practitioner Jacqueline Graziani have joined Mercy Health and are now accepting new neurology patients throughout Cleveland's west side.
Parkway Prosthodontics successfully completes a complex full-arch reconstruction for a patient with terminal dentition and significant bone loss, using advanced technology and interdisciplinary collaboration to restore function, confidence, and autonomy.
Postmortem Pathology today announced the opening of its new facility in Phoenix, bringing crucial private autopsy services to families throughout the area.
Curtana Pharmaceuticals Announces New Data Confirming CT-179 Effectively Crosses Blood-Brain Barrier and Synergizes with Radiation in Pediatric Brain Cancers
EPP Pricing Platform BV ("EPP"), the global, not-for-profit organisation dedicated to advancing the pricing and revenue growth management (RGM) profession, today announced a leadership transition as part of its long-term development and governance...
Preclinical Study Reveals that CT-179 Remodels the Tumor Microenvironment – Turning "Cold" Tumors "Hot" – and Significantly Enhancing the Efficacy of Immune Checkpoint Inhibitors
Stipenda, a leading Employer of Record (EOR) and Professional Employer Organization (PEO) provider, today announced the appointment of David Epstein as Chief Operating Officer (COO), effective 1 January 2026
Emerging biotech firm debuts "Science & Shield" initiative, bridging the gap between advanced medical research and immediate humanitarian relief for the Ozarks.
Christie Schofield and Randy Herbertson bring leadership in healthcare access, innovation, and brand strategy to advance supportive cancer care nationwide.
Biobase, a healthcare data infrastructure company pioneering the first agentic operating system for clinical data, received a strategic investment from BJC Health that will position BJC as a center of excellence for deploying next-generation AI solutions.
Platform delivers real-world evidence data for pharmaceutical research, hospital systems, insurance carriers, and senior living operators—achieving 87-91% accuracy in neurological disease detection
Bridging the orbital care gap: As NASA reassesses ISS medical protocols, Diopter Labs reveals a shelf-stable "clinic-in-a-lens" built to stop space-flight emergencies before they require evacuation.
NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP has Entered into a Joint Offering with neurocare Group for Neuroplastic Therapy Targeting Depression, PTSD and Other Mental Health Afflictions
VSee Health, Inc. (N A S D A Q: VSEE) $VSEE Reported Q3 Revenues Reach $3.98 Million, Up 19% Year-Over-Year with Clients Including NASA, U.S. Department of Health and Human Services, McKesson, DaVita and The Nation of Qatar
NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) NRXP Also Reports Its Superior Preservative-Free IV Ketamine Now Submitted for FDA Abbreviated New Drug Application
The Digital Pathology Market Size is projected to grow from USD 1.1 billion in 2022 to USD 2.9 billion by 2032 at a 10.3% CAGR, fueled by adoption of digital workflows, AI diagnostics, and global healthcare modernization.
The pipeline for pharmaceutical sales in 2026 is massive, and the projected numbers behind the next wave of drugs explain exactly why this career path is so attractive right now.
NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP: FDA Alignment, 70,000-Patient Real-World Data, and a Debt-Free Balance Sheet Position NRXP for Transformational 2026 Catalysts
MyAfroDNA, an African biotechnology company focused on advancing genomics research and innovation on the African continent, has announced the acquisition and deployment of the MGI CycloneSEQ™ genome sequencer, becoming the first facility in West Africa...
Precision Antibody, a leader in custom monoclonal antibody development, announces its participation in the Targeted Therapies Licensing & Partnering Summit Asia 2026, taking place February 26–27, 2026, in Meguro-ku, Tokyo, Japan.
Neurologist Dr. Brendan Bauer and Nurse Practitioner Jacqueline Graziani have joined Mercy Health and are now accepting new neurology patients throughout Cleveland's west side.
The Diabetes Drugs Market is projected to grow from USD 67.2 Billion in 2022 to USD 148.3 Billion by 2032 at a CAGR of 8.3%, driven by increasing diabetes prevalence, new drug classes, and treatment innovation.
Parkway Prosthodontics successfully completes a complex full-arch reconstruction for a patient with terminal dentition and significant bone loss, using advanced technology and interdisciplinary collaboration to restore function, confidence, and autonomy.
Postmortem Pathology today announced the opening of its new facility in Phoenix, bringing crucial private autopsy services to families throughout the area.
The Coenzyme Q10 Market is projected to grow from USD 618.3 million in 2022 to USD 1.51 billion by 2032 at a CAGR of 9.5%, driven by preventive health trends, aging populations, and expanding supplement use.
Curtana Pharmaceuticals Announces New Data Confirming CT-179 Effectively Crosses Blood-Brain Barrier and Synergizes with Radiation in Pediatric Brain Cancers
EPP Pricing Platform BV ("EPP"), the global, not-for-profit organisation dedicated to advancing the pricing and revenue growth management (RGM) profession, today announced a leadership transition as part of its long-term development and governance...
The Cardiovascular Drugs Market is projected to grow from USD 146.7 billion in 2023 to USD 210.3 billion by 2032 at a CAGR of 4.1%, driven by increased chronic disease prevalence, innovative therapies, and expanding global healthcare access.
Preclinical Study Reveals that CT-179 Remodels the Tumor Microenvironment – Turning "Cold" Tumors "Hot" – and Significantly Enhancing the Efficacy of Immune Checkpoint Inhibitors
The Cancer Immunotherapy Market is expected to grow from USD 114.3 billion in 2023 to USD 264.6 billion by 2032 at a CAGR of 9.9%, driven by innovations in checkpoint inhibitors, CAR-T therapies, and expanding immuno-oncology adoption.
Stipenda, a leading Employer of Record (EOR) and Professional Employer Organization (PEO) provider, today announced the appointment of David Epstein as Chief Operating Officer (COO), effective 1 January 2026
Dr.Abhay Kumar Pati, BAMS, MASF, Ph.d, D.Sc Physician, Researcher, Industrialist, Union City, C A 94587 Nutmeg offers benefits such as aiding digestion, promoting better sleep, and providing pain relief due to its anti-inflammatory and antioxidant...
Emerging biotech firm debuts "Science & Shield" initiative, bridging the gap between advanced medical research and immediate humanitarian relief for the Ozarks.
When it comes to sourcing high-quality clay materials for ceramics, pottery, and industrial applications, choosing a reliable ball clay supplier is essential.
Christie Schofield and Randy Herbertson bring leadership in healthcare access, innovation, and brand strategy to advance supportive cancer care nationwide.
The Herceptin Biosimilar Market is projected to grow from USD 2.9 billion in 2023 to USD 19.3 billion by 2032 at a CAGR of 23.6%, driven by expanding oncology treatment demand, biosimilar adoption, and healthcare affordability.
Biobase, a healthcare data infrastructure company pioneering the first agentic operating system for clinical data, received a strategic investment from BJC Health that will position BJC as a center of excellence for deploying next-generation AI solutions.
Platform delivers real-world evidence data for pharmaceutical research, hospital systems, insurance carriers, and senior living operators—achieving 87-91% accuracy in neurological disease detection
Bridging the orbital care gap: As NASA reassesses ISS medical protocols, Diopter Labs reveals a shelf-stable "clinic-in-a-lens" built to stop space-flight emergencies before they require evacuation.
CiRG Labs, a New York-based medical technology company, announced today a strategic partnership with Vinay Maheshwari to help grow the company's business and expand its clinical work globally.
SNS Intel is an Market Intelligence Platform for visual market intelligence across pharmaceutical and healthcare markets currently launching with Dermatology In Sight Module featuring in visual dashboards and Skin Cancer & Psoriasis as Focus areas
NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP has Entered into a Joint Offering with neurocare Group for Neuroplastic Therapy Targeting Depression, PTSD and Other Mental Health Afflictions
